Lindis Blood Care announces last patient out in multicenter clinical certification study REMOVE with CATUVAB® to eliminate tumor cells from surgical blood
Lindis Blood Care, a company aiming to set a new standard for blood management during cancer surgeries with its medical device CATUVAB® for the removal of tumor cells from surgical shed blood, today announced that the last patient in its…